2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2330

Construct Validity of the Adult Myopathy Assessment Tool in Individuals with Inclusion Body Myositis
Abstract Number: 2398

Continued Participation in a 10-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing Their BeSt?
Abstract Number: 2263

Continued Zoledronic Acid Use in a Large Healthcare System
Abstract Number: 2921

Contraceptive Factors Are Associated with Serum Antibodies to Citrullinated Protein Antigens in Women at Elevated Risk for Future Rheumatoid Arthritis
Abstract Number: L9

Contrast Enhanced Ultrasonography in Patients Diagnosed with Early Arthritis: A Preliminary Experience
Abstract Number: 2784

Contribution at the Spinal Level of Innate and Adaptive Immunity to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice
Abstract Number: 2090

Contribution of MTHFR Gene Polymorphisms in Sjogren’s Syndrome Related Lymphomagenesis
Abstract Number: 2219

Contribution of Tripartite Motif Proteins Modulating Membrane Repair to the Pathogenesis of Autoimmune-Mediated Myositis
Abstract Number: 1189

Conventional Magnetic Resonance Imaging (MR) and Hybrid 18F-Fluoride Positron Emission Tomography MRI (18F-F- PET/MRI) of the Spine and the Sacroiliac Joints – a Detailed Description of Pathologic Signals in Patients with Active Ankylosing Spondylitis
Abstract Number: 2767

Core Outcome Domains and Potential Measurement Instruments in polymyalgia Rheumatica (PMR) Using Omeract Filter 2.0
Abstract Number: 2639

Coronary-Artery Atherosclerosis in Males with Systemic Lupus Erythematosus
Abstract Number: 1338

Correlates of Body Image Dissatisfaction in Patients with Limited and Diffuse Systemic Sclerosis
Abstract Number: 229

Correlates of Heel Bone Mass in Young Adults: The Role of Cholesterol over 20 Years from Childhood to Early Adulthood
Abstract Number: 208

Correlates of Knee Bone Marrow Lesions in Younger Adults
Abstract Number: 2497

Correlation Between Time to Switch and Clinical Response Amplitude to Rituximab in Second Line Treatment in Rheumatoid Arthritis Patients with Treatment Failure to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat Observational Study

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].